- Not enactedThe President has not signed this bill
- The senate has not voted
- The house has not voted
Committee on Energy and CommerceIntroducedJanuary 10th, 2019
- house Committees
Prescription drug prices in the U.S. are incredibly high compared to Canada. Patients whose drugs are cheaper in Canada should be allowed to buy their drugs from there in order to keep their healthcare costs as low as possible.
Pharmaceutical companies need the revenue from their sales in the U.S. to fund innovative research that saves lives. Additionally, allowing personal importation from Canada might lead to unsafe or counterfeit medication entering the U.S., putting patients’ lives at risk.